RSS-Feed abonnieren
DOI: 10.1055/s-2008-1027466
© Georg Thieme Verlag KG Stuttgart · New York
Multimodale Therapie des Ösophaguskarzinoms
Multimodal Therapy of Esophageal CancerPublikationsverlauf
Manuskript eingetroffen: 30.7.2007
Manuskript akzeptiert: 16.4.2008
Publikationsdatum:
20. Oktober 2008 (online)

Zusammenfassung
Aufgrund der heutigen Studienlage muss die chirurgische Resektion nach wie vor als das Therapieverfahren der Wahl beim resektablen Ösophaguskarzinom gelten. Ein Überlebensvorteil durch neoadjuvante oder adjuvante Therapiemodalitäten gegenüber der alleinigen Resektion ist jedoch aufgrund der aktuellen Datenlage wahrscheinlich. Hierbei ist die neoadjuvante Radiochemotherapie in Kombination mit der chirurgischen Resektion beim Plattenepithelkarzinom am wirksamsten. Die tendenziell erhöhte perioperative Morbidität und Mortalität nach neoadjuvanter Radiochemotherapie ist durch die Zentrumschirurgie zu minimieren. Beim Adenokarzinom des gastroösophagealen Übergangs zeigte eine neoadjuvante Chemotherapie Vorteile gegenüber der alleinigen Resektion. Für Patienten, bei denen eine radikale Operation mit transthorakaler Tumorresektion ein zu hohes Operationsrisiko darstellt, ist das transhiatale Vorgehen bei distal gelegenen Tumoren zu bevorzugen. Besonders für Hochrisikopatienten mit Plattenepithelkarzinomen des Ösophagus ist zumindest im mittelfristigen Verlauf die alleinige Radiochemotherapie im Vergleich zur Resektion eine mögliche Alternative. Somit sollte heute das Ösophaguskarzinom ein individualisiertes, multimodales Therapiekonzept inklusive Chirurgie, Radiotherapie und Chemotherapie zur Behandlungsgrundlage haben.
Abstract
Surgery is still the treatment of choice in patients with resectable oesophageal cancer. However, recent randomised controlled trials suggest beneficial effects of adjuvant or neoadjuvant treatment modalities on progression-free and overall survival compared to surgery alone. Neoadjuvant chemoradiotherapy in combination with surgery is most effective in squamous cell carcinomas. Increased perioperative morbidity and mortality should be minimised by surgery in a high-volume centre. In adenocarcinomas of the gastro-oesophageal junction neoadjuvant chemotherapy shows beneficial effects compared to surgery alone. A transhiatal resection should be preferred in distal oesophageal cancer compared to a transthoracic oesophageal resection if the patient is in poor condition. In all other cases a transthoracic resection remains the procedure of choice. Chemoradiotherapy alone is an alternative to surgery in high-risk patients with squamous cell carcinomas of the oesophagus. Therefore the treatment of patients with oesophageal cancer should always include an individualised, multimodal approach including surgery, chemotherapy, and radiotherapy.
Schlüsselwörter
Ösophagusresektion - Radiotherapie - Radiochemotherapie - Chemotherapie
Key words
esophageal resection - radiotherapy - chemoradiotherapy - chemotherapy
Literatur
- 1
Bollschweiler E, Wolfgarten E, Gutschow C. et al .
Demographic variations in the rising incidence of esophageal adenocarcinoma in white
males.
Cancer.
2001;
92
549-555
MissingFormLabel
- 2
Hölscher A H, Bollschweiler E, Bumm R. et al .
Prognostic factors of resected adenocarcinoma of the esophagus.
Surgery.
1995;
118
845-855
MissingFormLabel
- 3
Roder J D, Busch R, Stein H J. et al .
Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell
carcinoma of the oesophagus.
Br J Surg.
1994;
81
410-413
MissingFormLabel
- 4
Birkmeyer J D, Siewers A E, Finlayson E V. et al .
Hospital volume and surgical mortality in the United States.
N Engl J Med.
2002;
346
1128-1137
MissingFormLabel
- 5
Birkmeyer J D, Stukel T A, Siewers A E. et al .
Surgeon volume and operative mortality in the United States.
N Engl J Med.
2003;
349
2117-2127
MissingFormLabel
- 6
Hulscher J B, Van Sandick J W, Boer A G. et al .
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma
of the esophagus.
N Engl J Med.
2002;
347
1662-1669
MissingFormLabel
- 7
Macadam de R, Sarela A, Wilson J. et al .
Bone marrow micrometastases predict early post-operative recurrence following surgical
resection of oesophageal and gastric carcinoma.
Eur J Surg Oncol.
2003;
29
450-454
MissingFormLabel
- 8
Bosset J F, Gignoux M, Triboulet J P. et al .
Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell
cancer of the esophagus.
N Engl J Med.
1997;
337
161-167
MissingFormLabel
- 9
Fiorica F, Di Bona D, Schepis F. et al .
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.
Gut.
2004;
53
925-930
MissingFormLabel
- 10
Lee J L, Park S I, Kim S B. et al .
A single institutional phase III trial of preoperative chemotherapy with hyperfractionation
radiotherapy plus surgery versus surgery alone for resectable esophageal squamous
cell carcinoma.
Ann Oncol.
2004;
15
947-954
MissingFormLabel
- 11
Malthaner R A, Wong R K, Rumble R B. et al .
Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review
and meta-analysis.
BMC Med.
2004;
2
35
MissingFormLabel
- 12
Gebski V, Burmeister B, Smithers B M. et al .
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal
carcinoma: a meta-analysis.
Lancet Oncol.
2007;
8
226-234
MissingFormLabel
- 13
Burmeister B H, Smithers B M, Gebski V. et al .
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of
the oesophagus: a randomised controlled phase III trial.
Lancet Oncol.
2005;
6
659-668
MissingFormLabel
- 14
Tepper J, Krasna M, Niedzwiecki D. et al .
Superiority of trimodality therapy to surgery alone in esophageal cancer: results
of CALGB 9781.
J Clin Oncol.
2006;
24 (Suppl 18S)
4012 (Abstract)
MissingFormLabel
- 15
Kok T, Lanschot J, Siersema P. et al .
Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: final report
of a phase III multicenter randomized controlled trial.
Proc Am Soc Clin Oncol.
1997;
16
277a (Abstract)
MissingFormLabel
- 16 Walsh T. The role of multimodality therapy in improving survival: a prospective randomized
trial. Predicting, defining and improving outcomes for esophageal carcinoma (MD thesis) Dublin; Trinity College, University of Dublin 1995: 124-150
MissingFormLabel
- 17
Malthaner R A, Collin S, Fenlon D.
Preoperative chemotherapy for resectable thoracic esophageal cancer.
Cochrane Database Syst Rev.
2006;
3
CD001556
MissingFormLabel
- 18
Malthaner R, Fenlon D.
Preoperative chemotherapy for resectable thoracic esophageal cancer.
Cochrane Database Syst Rev.
2001;
1
CD001556
MissingFormLabel
- 19
Medical Research Council Oesophageal Cancer Working Party .
Surgical resection with or without preoperative chemotherapy in oesophageal cancer:
a randomised controlled trial.
Lancet.
2002;
359
1727-1733
MissingFormLabel
- 20
Kelsen D P, Ginsberg R, Pajak T F. et al .
Chemotherapy followed by surgery compared with surgery alone for localized esophageal
cancer.
N Engl J Med.
1998;
339
1979-1984
MissingFormLabel
- 21
Cunningham D, Allum W H, Stenning S P. et al .
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.
N Engl J Med.
2006;
355
11-20
MissingFormLabel
- 22
Ando N, Iizuka T, Kakegawa T. et al .
A randomized trial of surgery with and without chemotherapy for localized squamous
carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study.
J Thorac Cardiovasc Surg.
1997;
114
205-209
MissingFormLabel
- 23
Ando N, Iizuka T, Ide H. et al .
Surgery Plus Chemotherapy Compared With Surgery Alone for Localized Squamous Cell
Carcinoma of the Thoracic Esophagus: A Japan Clinical Oncology Group Study –JCOG9204.
J Clin Oncol.
2003;
21
4592-4596
MissingFormLabel
- 24
Arnott S J, Duncan W, Gignoux M. et al .
Preoperative radiotherapy for esophageal carcinoma.
Cochrane Database Syst Rev.
2005;
19
CD001799
MissingFormLabel
- 25
Xiao Z F, Yang Z Y, Liang J. et al .
Value of radiotherapy after radical surgery for esophageal carcinoma: a report of
495 patients.
Ann Thorac Surg.
2003;
75
331-336
MissingFormLabel
- 26
Kaklamanos I G, Walker G R, Ferry K. et al .
Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal
junction: a meta-analysis of randomized clinical trials.
Ann Surg Oncol.
2003;
10
754-761
MissingFormLabel
- 27
Urschel J D, Vasan H.
A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation
and surgery to surgery alone for resectable esophageal cancer.
Am J Surg.
2003;
185
538-543
MissingFormLabel
- 28
Kleinberg L, Gibson M K, Forastiere A A.
Chemoradiotherapy for localized esophageal cancer: regimen selection and molecular
mechanisms of radiosensitization.
Nat Clin Pract Oncol.
2007;
4
282-294
MissingFormLabel
- 29
Araujo C M, Souhami L, Gil R A. et al .
A randomized trial comparing radiation therapy versus concomitant radiation therapy
and chemotherapy in carcinoma of the thoracic esophagus.
Cancer.
1991;
67
2258-2261
MissingFormLabel
- 30
Smith T J, Ryan L M, Douglass H OJ. et al .
Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma
of the esophagus: a study of the Eastern Cooperative Oncology Group.
Int J Radiat Oncol Biol Phys.
1998;
42
269-276
MissingFormLabel
- 31
Slabber C F, Nel J S, Schoeman L. et al .
A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and
platinum in patients with inoperable, locally advanced squamous cancer of the esophagus.
Am J Clin Oncol.
1998;
21
462-465
MissingFormLabel
- 32
Herskovic A, Martz K, al-Sarraf M. et al .
Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients
with cancer of the esophagus.
N Engl J Med.
1992;
326
1593-1598
MissingFormLabel
- 33
Cooper J S, Guo M D, Herskovic A. et al .
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a
prospective randomized trial (RTOG 85 – 01). Radiation Therapy Oncology Group.
JAMA.
1999;
281
1623-1627
MissingFormLabel
- 34
Stahl M, Stuschke M, Lehmann N. et al .
Chemoradiation with and without surgery in patients with locally advanced squamous
cell carcinoma of the esophagus.
J Clin Oncol.
2005;
23
2310-2317
MissingFormLabel
- 35
Bedenne L, Michel P, Bouche O. et al .
Chemoradiation followed by surgery compared with chemoradiation alone in squamous
cancer of the esophagus: FFCD 9102.
J Clin Oncol.
2007;
25
1160-1168
MissingFormLabel
- 36
Luthra R, Wu T T, Luthra M G. et al .
Gene expression profiling of localized esophageal carcinomas: association with pathologic
response to preoperative chemoradiation.
J Clin Oncol.
2006;
24
259-267
MissingFormLabel
- 37
Levine E A, Farmer M R, Clark P. et al .
Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET)
in the identification of responders to chemoradiation therapy for the treatment of
locally advanced esophageal cancer.
Ann Surg.
2006;
243
472-478
MissingFormLabel
- 38
Flamen P, Van Cutsem E, Lerut A. et al .
Positron emission tomography for assessment of the response to induction radiochemotherapy
in locally advanced oesophageal cancer.
Ann Oncol.
2002;
13
361-368
MissingFormLabel
- 39
Lordick F, Ott K, Krause B J. et al .
PET to assess early metabolic response and to guide treatment of adenocarcinoma of
the oesophagogastric junction: the MUNICON phase II trial.
Lancet Oncol.
2007;
8
797-805
MissingFormLabel
Prof. Dr. Jens Werner
Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Universität Heidelberg
Im Neuenheimer Feld 110
69120 Heidelberg
Telefon: ++ 49/62 21/56 51 50
Fax: ++ 49/62 21/56 59 69
eMail: jens_werner@med.uni-heidelberg.de